Skip to main content.

Tritanium® C Anterior Cervical Cage

Specialties:

Interbody

Description:

The Tritanium C Anterior Cervical Cage is a hollow, rectangular implant that consists of a unique configuration of both solid and porous structures built using AMagine Technology, our proprietary approach to implant creation using additive manufacturing.

Features and benefits:

  • Our proprietary Tritanium In-Growth Technology, used to build the Tritanium C Cage, was designed for bone in-growth and biological fixation[1]
  • Unique porous structure of Tritanium Technology is designed to create a favorable environment for cell attachment and proliferation[2][3] and may be able to wick or retain fluid when compared to traditional titanium material[4]
  • Porous structures feature randomized pore shape and sizing that are designed to mimic cancellous bone[3][5]
  • Interconnected pore structure from endplate to endplate[3]
  • Compared to other available materials for ACDF, offers no risk of donor infection, no donor lot variability, no special tracking or distribution and no special preparation (i.e., soaking)
  • Created to allow imaging[6]
  • Shaped for stability[7][8]
  • Developed to minimize subsidence[9]
 
For more information

  1. ^Tritanium Technology Claim Support Memo PROJ 43909
  2. ^Tritanium cell infiltration and attachment experiment RD0000053710
  3. ^Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26(27):5474–91
  4. ^Tritanium material capillary evaluation RD0000050927
  5. ^Tritanium C 510(k) Physical Testing Report DHF0000053171
  6. ^Tritanium C implant imaging marketing memo PROJ0000054459
  7. ^Tritanium C insertion and expulsion marketing memo PROJ0000054458
  8. ^Coefficient of friction memo PROJ44960
  9. ^Tritanium C subsidence marketing memo PROJ0000054457
Literature Number: TRICC-WB-2_18483

Resource center

 

United States/English

A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it in a procedure/surgery.

The information presented is intended to demonstrate the breadth of Stryker product offerings. A healthcare professional must always refer to the package insert, product label and/or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.

Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Aero, Berchtold, BIO4, Clarity, CORE, Cranial iD, CranialMap, CranialMask, DirectInject, DuraMatrix, πdrive, ES2, Everest, Excelsior, FlowGate, Gateway, HydroSet, iSuite, iVAS, LITe, Maestro, Malis, MEDPOR, Mesa, MultiGen, Nano, Neuroform EZ, OASYS, SL-10, SDC3, Serengeti, Serrato, SILVERGlide, Sonopet, Spetzler, SpineJack, SpineMap, SpineMask, Stentriever, Streamline, Stryker, Stryker iD, Stryker NAV3i, Switchpoint Infinity, Synchro, Target, Target XL, TransForm, Trevo, Tritanium, Universal Neuro, Venom, Vitoss, VLIFT, Wingspan, Xia, XT-17, XT-27. All other trademarks are trademarks of their respective owners or holders.

The absence of a product, feature, or service name, or logo from this list does not constitute a waiver of Stryker’s trademark or other intellectual property rights concerning that name or logo.

DuraMatrix is a registered trademark of Collagen Matrix, Inc.

BIO4 is manufactured by Osiris Therapeutics, Inc.

Cookie disclaimer

Privacy policy

Terms of use

Surgeon disclaimer

©2019 Stryker 4100 East Milham Avenue Kalamazoo, MI 49001 US